Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,079) with videos related to
Page
of 108
Sort By:
BMC Cancer
|
February 4, 2014
A panel of genes methylated with high frequency in colorectal cancer
Susan M Mitchell, Jason P Ross, Horace R Drew, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice
M W Holladay, H Bai, Y Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Plasma proteome-wide analysis of cerebral small vessel disease identifies novel biomarkers and disease pathways
Gabriela T Gomez, Liu Shi, Alison E Fohner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
J Alvarez, Q Shi, A Dasari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 15, 2023
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Liu Shi, Jin Xu, Rebecca Green, et al.
JAMA Neurology
|
May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
David A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Stem Cells (Dayton, Ohio)
|
December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markers
Helen A Rowland, Georgina Miller, Qiang Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist
Gerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Stephen Salloway, Jose E Gamez, Upinder Singh, et al.
Biochemical Pharmacology
|
March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity
Marlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Page
of 108
Search research articles
Search
Showing results (1061-1070 of 1,079) with videos related to
Sort By:
Page
of 108
BMC Cancer
|
February 4, 2014
A panel of genes methylated with high frequency in colorectal cancer
Susan M Mitchell, Jason P Ross, Horace R Drew, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice
M W Holladay, H Bai, Y Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Plasma proteome-wide analysis of cerebral small vessel disease identifies novel biomarkers and disease pathways
Gabriela T Gomez, Liu Shi, Alison E Fohner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
J Alvarez, Q Shi, A Dasari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 15, 2023
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Liu Shi, Jin Xu, Rebecca Green, et al.
JAMA Neurology
|
May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
David A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Stem Cells (Dayton, Ohio)
|
December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markers
Helen A Rowland, Georgina Miller, Qiang Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist
Gerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Stephen Salloway, Jose E Gamez, Upinder Singh, et al.
Biochemical Pharmacology
|
March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity
Marlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Page
of 108